Bruker Daltonics has entered into a framework agreement with Synlab for molecular microbial identification based on Maldi-Tof mass spectrometry.
Reportedly, both the companies have concluded a partnership agreement in order to equip the laboratories of the Synlab association exclusively with the Maldi Biotyper system for fast and reliable molecular microbial identification. The Maldi Biotyper is currently in routine use in Synlab’s clinical microbiology centers in Trier, Weiden and Dachau in Germany.
Moreover, Bruker and Synlab plan to further enlarge and refine the Maldi Biotyper reference library using well defined clinical isolates from the daily microbiology routine work of the Synlab laboratories.
The Maldi Biotyper is integrated into the Synlab laboratories’ microbiology workflow, combining fast molecular identification with conventional antibiotic susceptibility testing (AST). The Maldi Biotyper reports the identification results into the existing laboratory information systems (LIS).
Ulrich Knipp, technical head of microbiology at Synlab in Trier, said: “After evaluating the Maldi Biotyper very thoroughly within the Synlab group, we are convinced that Bruker Daltonics is the most reliable partner for microbial identification based on mass spectrometry, and is providing microbiological service and support.”
Guido Mix, director of microbiology at Bruker Daltonics, said: “Our framework contract with Synlab validates our efforts to provide comprehensive service and applications support to our customers by our dedicated microbiologists, fully developed technicians network and dedicated IT specialists for integration into various laboratory information systems (LIS).”